research and patient care at The Neuro

2018 Wilder Penfield Lecture: Victor J. Dzau, MD, President of the US National Academy of Medicine and Vice Chair of the US National Research Council


Montreal Neurological Institute Jeanne Timmins Amphitheatre, 3801 rue University, Montreal, QC, H3A 2B4, CA

Dr. Victor Dzau

President of the U.S. National Academy of Medicine and Vice-Chair of the U.S. National Research Council
Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University



Victor J. DZAU, MD, is President of the US National Academy of Medicine and Vice Chair of the US National Research Council. He is an internationally acclaimed healthcare leader and one of the most influential physician scientists globally. His seminal work in cardiovascular medicine and genetics laid the foundation for development of the class of lifesaving drugs known as ACE inhibitors, used globally to treat hypertension and heart failure. Dr. Dzau pioneered gene therapy for vascular disease and cardiac regeneration by microRNA induced direct reprogramming. He was the first to introduce DNA decoy molecules to block transcription as gene therapy in humans. At the National Academies, Dr Dzau has designed and led important initiatives such as the Commission on a Global Health Risk Framework for the Future; the Human Gene Editing Initiative; Vital Directions for Health and Health Care and the Grand Challenge in Healthy Longevity.

He is a former chair of NIH’s Cardiovascular Disease Advisory Committee and is past chair of the Association of Academic Health Centers. Currently, he chairs the NIH Cardiovascular Progenitor Cell Consortium, the Scientific Boards of Qatar Genome Project, and Institute of Cardiovascular and Medical Sciences of University of Glasgow. He is a member of the Health Biomedical Sciences Council of Singapore. He chaired the World Economic Forum’s Global Agenda Council on Precision Medicine and now chairs the Global Futures Council on Human Enhancement and Aging.

Previously, Dr. Dzau has served as Chancellor of Duke University, CEO of Duke Health System, and Chair of Medicine at Stanford and Harvard Universities. He has received numerous awards including the Max Delbruck Medal from Berlin, the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Polzer Prize from the European Academy of Sciences & Arts, the Ellis Island Medal of Honor, McGill Alumni Global Lifetime Achievement Award and the Henry Friesen International Prize.and the Distinguished Scientist Award of the American Heart Association.

Proud of his McGill education and Canadian roots, Dzau has given his time generously to serve Canada, including as a member of the International Review Panel for the CIHR, past chairman of the External Board of the McClaughlin Center of Molecular Medicine of the University of Toronto, the Canada Gairdner Award Medical Advisory Board, Board of Directors of the Gairdner Foundation, the Scientific Board of the University Health Network of Toronto, the International Review Board of the Ontario Research and Development Challenge Fund, the Review Board for the Canadian Excellence in Research Chairs and currently Chairs the Scientific Advisory Board of Peter Munk Cardiac Center, Toronto, and Chair of the Advisory Board of the new School of Population & Global Health at McGill and among many others.

Contact Information

Deborah Rashcovsky
Montreal Neurological Institute and Hospital
debbie.rashcovsky [at]
Office Phone: 
(514) 398-6047

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

The Neuro is a McGill research and teaching institute; delivering the highest quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.